TRIANA Biomedicines and Pfizer Enter Into A Research Collaboration to Discover Novel Molecular Glue Degraders for Multiple Disease Areas
TRIANA will receive an upfront payment of $49 million, and is eligible to receive future milestone payments and royalties LEXINGTON,...
